RushNet Inc RSHN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.72 Mil
- Volume/Avg
- 172,000 / 9.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians with individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments and the latest software for patient and physician satisfaction. It allows heliosDX to provide physicians with fast and accurate reporting meetings. The firm excels in patient and client care through physician-designed panels that aid in testing compliance and reporting education.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.rushnetinc.com
Valuation
|
Metric
|
RSHN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RSHN
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
RSHN
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Hftgrlbgmg | Wtdm | $231.8 Bil | |||
| Danaher Corp
DHR
| Mdfcnzpbcd | Gtwksx | $197.8 Bil | |||
| IQVIA Holdings Inc
IQV
| Bdvqjxvqb | Jznkdz | $43.7 Bil | |||
| Agilent Technologies Inc
A
| Wfspmxgxx | Hyn | $40.1 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Qlzjfbfnbn | Ybfhrm | $38.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Skycxctr | Zsdkj | $31.0 Bil | |||
| Icon PLC
ICLR
| Cyxchxwv | Rgjvvt | $26.8 Bil | |||
| Illumina Inc
ILMN
| Pjrfsxcj | Xgrbpkp | $19.2 Bil | |||
| Waters Corp
WAT
| Pzrdxdlvc | Gmpfd | $18.9 Bil | |||
| Labcorp Holdings Inc
LH
| Sxtczbvqws | Nfsbkm | $17.8 Bil |